- Home
- MBX vs CDRO Comparison
MBX vs CDRO Comparison
Compare MBX & CDRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBX
- CDRO
- Stock Information
- Founded
- MBX 2018
- CDRO 2014
- Country
- MBX United States
- CDRO Luxembourg
- Employees
- MBX N/A
- CDRO N/A
- Industry
- MBX
- CDRO Services-Misc. Amusement & Recreation
- Sector
- MBX
- CDRO Consumer Discretionary
- Exchange
- MBX NYSE
- CDRO Nasdaq
- Market Cap
- MBX 381.4M
- CDRO 381.1M
- IPO Year
- MBX 2024
- CDRO N/A
- Fundamental
- Price
- MBX $13.75
- CDRO $8.26
- Analyst Decision
- MBX Strong Buy
- CDRO Strong Buy
- Analyst Count
- MBX 6
- CDRO 1
- Target Price
- MBX $37.50
- CDRO $10.00
- AVG Volume (30 Days)
- MBX 498.6K
- CDRO 30.8K
- Earning Date
- MBX 08-16-2025
- CDRO 07-31-2025
- Dividend Yield
- MBX N/A
- CDRO N/A
- EPS Growth
- MBX N/A
- CDRO N/A
- EPS
- MBX N/A
- CDRO 0.08
- Revenue
- MBX N/A
- CDRO $207,789,626.00
- Revenue This Year
- MBX N/A
- CDRO $13.97
- Revenue Next Year
- MBX N/A
- CDRO $8.37
- P/E Ratio
- MBX N/A
- CDRO $99.73
- Revenue Growth
- MBX N/A
- CDRO 24.16
- 52 Week Low
- MBX $4.81
- CDRO $5.75
- 52 Week High
- MBX $27.50
- CDRO $8.76
- Technical
- Relative Strength Index (RSI)
- MBX N/A
- CDRO 49.96
- Support Level
- MBX N/A
- CDRO $8.20
- Resistance Level
- MBX N/A
- CDRO $8.50
- Average True Range (ATR)
- MBX 0.00
- CDRO 0.35
- MACD
- MBX 0.00
- CDRO -0.04
- Stochastic Oscillator
- MBX 0.00
- CDRO 23.44
About MBX MBX BIOSCIENCES INC
MBX Biosciences Inc is a clinical stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders. The company designed its proprietary Precision Endocrine Peptide, or PEP, platform to overcome the key limitations of unmodified and modified peptide therapies to improve clinical outcomes and simplify disease management for patients. Its PEPs are selectively engineered to have optimized pharmaceutical properties, including extended time-action profiles and consistent drug concentrations with low peak-to-trough concentration ratios, consistent exposure to target tissues, and less frequent dosing. Its product candidates include MBX 2109, MBX 1416, and MBX 4291.
About CDRO Codere Online Luxembourg S.A.
Codere Online Luxembourg SA is an international online casino gaming and online sports betting group focused on providing its customers with a safe and enjoyable online gaming experience. It currently operates in Spain, Mexico, Colombia, and Other countries. where it offers its users the ability to play online casino games and bet on sports events. Online casino offerings include the full portfolio of games typically available in land-based casinos, gaming halls and gambling establishments, such as slot machines, table games, and bingo. Online sports betting involves a user placing a wager on an event at some fixed odds determined by Codere Online. The company derives maximum revenue from Mexico.